ADIPOQ and rheumatoid arthritis: The differences in adiponectin and their receptor expressions in tissues of RA and OA patients may be a result of different inflammatory status in RA and OA patients (strong inflammation in RA vs. weak inflammation in OA patients), and post-transcriptional modifications.